IRIS
ALTAMURA, CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.814
AS - Asia 1.291
EU - Europa 1.242
SA - Sud America 365
Continente sconosciuto - Info sul continente non disponibili 240
AF - Africa 79
OC - Oceania 3
Totale 6.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.719
IT - Italia 485
SG - Singapore 485
BR - Brasile 296
CN - Cina 222
RU - Federazione Russa 175
DE - Germania 174
BD - Bangladesh 139
HK - Hong Kong 113
SE - Svezia 109
VN - Vietnam 105
GB - Regno Unito 86
FR - Francia 69
IN - India 61
FI - Finlandia 52
CA - Canada 38
ID - Indonesia 35
CI - Costa d'Avorio 23
AR - Argentina 22
TR - Turchia 22
NL - Olanda 18
JP - Giappone 17
ZA - Sudafrica 17
PL - Polonia 16
EC - Ecuador 15
MX - Messico 15
IQ - Iraq 14
VE - Venezuela 13
CO - Colombia 11
CR - Costa Rica 11
BE - Belgio 10
UA - Ucraina 9
UZ - Uzbekistan 9
ES - Italia 8
PH - Filippine 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
HN - Honduras 6
NP - Nepal 6
TN - Tunisia 6
AT - Austria 5
EG - Egitto 5
JO - Giordania 5
MA - Marocco 5
PK - Pakistan 5
SC - Seychelles 5
SV - El Salvador 5
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
IL - Israele 4
LT - Lituania 4
LY - Libia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MY - Malesia 3
NI - Nicaragua 3
AL - Albania 2
CG - Congo 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
IE - Irlanda 2
JM - Giamaica 2
KZ - Kazakistan 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IM - Isola di Man 1
IR - Iran 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PT - Portogallo 1
Totale 5.792
Salva come PNG Salva come JPEG
Città #
Ashburn 395
Singapore 255
Fairfield 217
San Jose 202
Chandler 133
Houston 119
Hong Kong 111
Milan 109
Woodbridge 107
Beijing 96
Nyköping 86
Dallas 83
Council Bluffs 76
Cambridge 73
New York 68
Bari 66
Seattle 66
Los Angeles 62
Wilmington 60
Ann Arbor 58
Rome 45
Lauterbourg 42
Santa Clara 37
Helsinki 36
Ho Chi Minh City 30
Buffalo 26
Jakarta 26
Abidjan 23
Hanoi 23
Roxbury 23
Boardman 22
Columbus 22
Lawrence 21
São Paulo 21
Inglewood 20
Brooklyn 18
Jacksonville 18
Chennai 17
Des Moines 17
Falkenstein 17
Tokyo 17
Chicago 16
London 15
Moscow 15
San Diego 15
Atlanta 14
Frankfurt am Main 14
Munich 14
Nanjing 14
North Bergen 13
Phoenix 13
Figino 12
Warsaw 12
Washington 12
Montreal 11
Salvador 11
San José 11
Dong Ket 10
Naples 10
Poplar 10
Ankara 9
Brasília 9
Florence 9
Grottaglie 9
Paris 9
Rio de Janeiro 9
Denver 8
Johannesburg 8
Nuremberg 8
Orem 8
Turku 8
Baghdad 7
Brussels 7
Curitiba 7
Guayaquil 7
Princeton 7
Pune 7
Tashkent 7
The Dalles 7
Charlotte 6
Delhi 6
Jeddah 6
Montignoso 6
Stockholm 6
Toronto 6
Turin 6
Wuhan 6
Amman 5
Las Vegas 5
Manchester 5
Medellín 5
Mexico City 5
Salt Lake City 5
Sorocaba 5
Taranto 5
Amsterdam 4
Araraquara 4
Augusta 4
Boston 4
Caracas 4
Totale 3.463
Salva come PNG Salva come JPEG
Nome #
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within CBS2 domain and C-terminal peptide of ClC-1 channel 323
ClC-1 chloride channels: state-of-the-art research and future challenges 234
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 221
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid 219
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate 216
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 212
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation 201
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 194
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 176
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 175
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia 173
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo 170
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels 160
Emerging roles for ion channels in ovarian cancer: Pathomechanisms and pharmacological treatment 150
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 147
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities 145
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 134
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. 130
Ion channels gene expression analysis in myotonia congenita patients carrying ClC-1 chloride channel mutations 123
Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy 123
Skeletal muscle ClC-1 chloride channels in health and diseases 121
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia 120
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome 116
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 115
Drug repurposing in skeletal muscle ion channelopathies 114
Ion Channel Involvement in Tumor Drug Resistance 113
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine 109
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 106
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 106
Natural ClC-1 mutations causing myotonia congenita reduce sensitivity to 9-AC 105
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 103
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 102
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 98
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 97
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 97
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model 97
Buprenorphine may be effective for treatment of paramyotonia congenita 95
Pharmacological therapy of non-dystrophic myotonias 93
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies? 87
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 87
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 80
Hunting for lubeluzole analogues as antimyotonic agents with reduced cardiac liability 79
NSAIDS AS MODULATORS OF CATION CHANNELS: FENAMATES REPURPOSING IN CHANNELOPATHIES 69
Target mutation-driven drug discovery 65
null 29
Electronic Devices and Digital Therapeutics in Neuromuscular Diseases: Narrative Review on Current Applications in Patients' Management and Pharmacovigilance 5
Totale 6.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022182 0 0 0 0 4 14 4 11 16 40 42 51
2022/2023356 35 54 33 17 24 52 11 54 46 9 14 7
2023/2024197 8 30 15 21 25 61 3 4 5 8 8 9
2024/20251.000 42 4 43 40 97 80 185 105 49 43 130 182
2025/20262.530 301 110 181 239 278 140 222 71 328 197 159 304
2026/2027556 61 93 115 268 19 0 0 0 0 0 0 0
Totale 6.034